BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1658525)

  • 1. Enzyme-histochemical studies of griseofulvin-intoxicated mouse livers.
    Woltsche M; Zatloukal K; Denk H
    Liver; 1991 Aug; 11(4):231-40. PubMed ID: 1658525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excretory function in cultured hepatocytes from griseofulvin-treated mice.
    Kawahara H; Marceau N; French SW
    Lab Invest; 1989 Dec; 61(6):609-22. PubMed ID: 2481150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of cytokeratin filament organization in human and murine Mallory body-containing livers as revealed by a panel of monoclonal antibodies.
    Preisegger KH; Zatloukal K; Spurej G; Denk H
    Liver; 1991 Oct; 11(5):300-9. PubMed ID: 1720496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver.
    Hutter H; Zatloukal K; Winter G; Stumptner C; Denk H
    Lab Invest; 1993 Nov; 69(5):576-82. PubMed ID: 7504119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifications in cytokeratin and actin in cultured liver cells derived from griseofulvin-fed mice.
    Cadrin M; Anderson NM; Aasheim LH; Kawahara H; Franks DJ; French SW
    Lab Invest; 1995 Apr; 72(4):453-60. PubMed ID: 7536860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fate of Mallory body-containing hepatocytes: disappearance of Mallory bodies and restoration of the hepatocytic intermediate filament cytoskeleton after drug withdrawal in the griseofulvin-treated mouse.
    Zatloukal K; Spurej G; Rainer I; Lackinger E; Denk H
    Hepatology; 1990 Apr; 11(4):652-61. PubMed ID: 1691733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products.
    Preisegger KH; Stumptner C; Riegelnegg D; Brown PC; Silverman JA; Thorgeirsson SS; Denk H
    Hepatology; 1996 Jul; 24(1):248-52. PubMed ID: 8707270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of protein composition of nuclear lamina. Reduction of lamins B1 and B2 in livers of griseofulvin-treated mice.
    Zatloukal K; Denk H; Spurej G; Hutter H
    Lab Invest; 1992 May; 66(5):589-97. PubMed ID: 1573853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of Mallory body, intermediate filament, and microfilament proteins in liver cell primary cultures. An electron microscopic autoradiography assay.
    Kachi K; Cadrin M; French SW
    Lab Invest; 1993 Jan; 68(1):71-81. PubMed ID: 7678660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mallory body formation runs parallel to gamma-glutamyl transferase induction in hepatocytes of griseofulvin-fed mice.
    Tazawa J; Irie T; French SW
    Hepatology; 1983; 3(6):989-1001. PubMed ID: 6138303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural, biochemical, and immunologic characterization of Mallory bodies in livers of griseofulvin-treated mice. Fimbriated rods of filaments containing prekeratin-like polypeptides.
    Franke WW; Denk H; Schmid E; Osborn M; Weber K
    Lab Invest; 1979 Feb; 40(2):207-20. PubMed ID: 219290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin is present on the cytokeratin intermediate filaments and Mallory bodies of hepatocytes.
    Ohta M; Marceau N; Perry G; Manetto V; Gambetti P; Autilio-Gambetti L; Metuzals J; Kawahara H; Cadrin M; French SW
    Lab Invest; 1988 Dec; 59(6):848-56. PubMed ID: 2462130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of desmosomes in mouse hepatocytes after drug-induced rearrangement of cytokeratin filament material. Demonstration of independence of desmosomes and intermediate-sized filaments.
    Denk H; Lackinger E; Cowin P; Franke WW
    Exp Cell Res; 1985 Nov; 161(1):161-71. PubMed ID: 2414118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of Mallory bodies to intermediate filaments in hepatocytes. A scanning electron microscopy study.
    Okanoue T; Ohta M; Ou O; Kachi K; Kagawa K; Yuki T; Okuno T; Takino T; French SW
    Lab Invest; 1985 Nov; 53(5):534-40. PubMed ID: 2414564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of Mallory bodies to the cytoskeleton of hepatocytes in griseofulvin-treated mice.
    Irie T; Benson NC; French SW
    Lab Invest; 1982 Oct; 47(4):336-45. PubMed ID: 6889660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver.
    Katsuma Y; Swierenga SH; Khettry U; Marceau N; French SW
    Hepatology; 1987; 7(6):1215-23. PubMed ID: 2445643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High molecular weight component of Mallory bodies detected by a monoclonal antibody.
    Zatloukal K; Denk H; Spurej G; Lackinger E; Preisegger KH; Franke WW
    Lab Invest; 1990 Apr; 62(4):427-34. PubMed ID: 1692099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Posttranslational events involved in griseofulvin-induced keratin cytoskeleton alterations.
    Salmhofer H; Rainer I; Zatloukal K; Denk H
    Hepatology; 1994 Sep; 20(3):731-40. PubMed ID: 7521318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid-induced Mallory body formation in drug-primed mouse liver.
    Fickert P; Trauner M; Fuchsbichler A; Stumptner C; Zatloukal K; Denk H
    Am J Pathol; 2002 Dec; 161(6):2019-26. PubMed ID: 12466118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the three-dimensional structure of quick-frozen hepatic Mallory bodies with special reference to the appearance of cytoplasmic vesicles.
    Irie T; Koyama W; Ikeuchi Y; Kanaseki T
    Cell Struct Funct; 1991 Feb; 16(1):1-16. PubMed ID: 1709594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.